Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma

Clinicopathological features and prognosis of TFE3-positive renal cell carcinoma

BackgroundThis study aimed to investigate the expression profile of TFE3 in renal cell carcinoma (RCC) and the clinicopathological features as well as prognosis of TFE3-positive RCC.MethodsTissue sections from 796 patients with RCC were collected for immunohistochemical staining of TFE3. Molecular T...

Full description

Bibliographic Details
Main Authors:	Xiang Dong, Yuxin Chen, Jun Pan, Wenliang Ma, Peng Zhou, Ming Chen, Hongqian Guo, Weidong Gan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Oncology
Subjects:	TFE3 Xp11.2 translocation RCC (Renal Cell Carcinoma) Clinico pathologic characteristics prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1017425/full

Similar Items

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
by: Jiale Zhou, et al.
Published: (2022-07-01)

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners
by: Yan Ge, et al.
Published: (2021-11-01)

The incidence of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion in Saudi adult patients with renal cancer: a retrospective tissue microarray analysis
by: Jaudah Al-Maghrabi, et al.
Published: (2019-01-01)

Gender difference analysis of Xp11.2 translocation renal cell carcinomas’s attack rate: a meta-analysis and systematic review
by: Wenyuan Zhuang, et al.
Published: (2020-08-01)

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
by: Wei Guo, et al.
Published: (2023-02-01)

Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?
by: Wenliang Ma, et al.
Published: (2020-12-01)

Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis
by: Zhu Y, et al.
Published: (2021-03-01)

Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma
by: Arash Akhavein, et al.
Published: (2014-05-01)

TFE3-rearranged renal cell carcinoma with osseous metaplasia and indolent behaviour
by: Alessandro Pietro Aldera, et al.
Published: (2022-05-01)

Case Reports of TFE3-Rearranged Renal Cell Carcinoma: FDG-PET Uptake Might Help Diagnosis
by: Sho Murakami, et al.
Published: (2023-09-01)

Bilateral Xp11.2 translocation renal cell carcinoma: a case report
by: Takashi Karashima, et al.
Published: (2018-11-01)

The preliminary experiences of translocation renal cell carcinoma and literature review
by: Hsin-Hao Su, et al.
Published: (2014-08-01)

Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma
by: Ning Liu, et al.
Published: (2022-04-01)

Estradiol increases risk of topoisomerase IIβ-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma
by: Qiancheng Shi, et al.
Published: (2021-11-01)

TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma
by: Junyi Lin, et al.
Published: (2023-05-01)

A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic TFE3-rearranged renal cell carcinoma:a case report
by: Haiyang Yang, et al.
Published: (2023-10-01)

MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report
by: Kaihang Yang, et al.
Published: (2023-07-01)

Sarcomatoid variant of Xp11 translocation renal cell carcinoma: A rare case report in an adult female
by: Rakhi V Jagdale, et al.
Published: (2024-01-01)

Melanotic Xp11 translocation renal cancer: a report of a distinctive case and a review of the literature
by: Hongbiao Jing, et al.
Published: (2018-08-01)

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients
by: Sezim Agizamhan, et al.
Published: (2018-06-01)

MiT/TFE Family Renal Cell Carcinoma
by: Jinglong Tang, et al.
Published: (2023-01-01)

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
by: Huizhi Zhang, et al.
Published: (2023-01-01)

Morphological spectrum of Xp11. Translocation-Associated Renal Cell Carcinoma in a Developing Country
by: Iram Khan, et al.
Published: (2022-11-01)

Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers
by: Jee Soo Park, et al.
Published: (2022-01-01)

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report
by: Juping Zhao, et al.
Published: (2022-08-01)

Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
by: Wenpeng Huang, et al.
Published: (2023-09-01)

Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
by: Shuping Wei, et al.
Published: (2019-12-01)

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
by: Audrey Simonaggio, et al.
Published: (2022-07-01)

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
by: Martin Lang, et al.
Published: (2023-04-01)

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge
by: Anna Caliò, et al.
Published: (2019-08-01)

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features
by: Kentaro Inamura
Published: (2017-08-01)

Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3
by: Xiang Ju, et al.
Published: (2020-12-01)

Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) – A Case Study and Review of the Literature
by: Ignacy Miroński, et al.
Published: (2022-01-01)

Emerging roles and regulation of MiT/TFE transcriptional factors
by: Min Yang, et al.
Published: (2018-06-01)

Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion
by: Paulo G. O. Salles, et al.
Published: (2005-06-01)

A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3‐rearranged renal cell carcinoma
by: Pengju Li, et al.
Published: (2024-03-01)

TFE3-rearranged renal cell carcinoma with tumour thrombus in the ureter mimicking invasive transitional cell carcinoma
by: Arman Z. Chacko, et al.
Published: (2023-11-01)

LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD+ kinase-independent manner
by: Yi Chen, et al.
Published: (2023-09-01)

Melanotic Xp11 Translocation Renal Cancer Managed With Radical Nephrectomy and IVC Tumor Thrombectomy
by: Iyad S. Khourdaji, et al.
Published: (2017-01-01)

Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities
by: Yang Liu, et al.
Published: (2023-04-01)